Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Aug 8, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal, the San …
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects technical …
Recursion OS:
By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high-potential …
LOWE - Recursion
Within Recursion, this process typically requires biologists to delineate biological pathways and establish novel map relationships, followed by chemists optimizing chemical series for the selected targets.
Recursion Reports Third Quarter 2025 Financial Results and Provides ...
Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia, two leaders ...
Nov 20, 2024 · “I believe the combination of the incredible teams and platforms at Exscientia and Recursion position us as the leader of the AI-enabled drug discovery and development space,” said …
Recursion Pharmaceuticals, Inc. - Press Releases
Oct 28, 2025 · Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, …
Recursion Pharmaceuticals, Inc.
Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias.